Filing Details

Accession Number:
0001127602-24-002738
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-31 16:23:50
Reporting Period:
2024-01-29
Accepted Time:
2024-01-31 16:23:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492422 Apellis Pharmaceuticals Inc. APLS Pharmaceutical Preparations (2834) 271537290
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1827326 Jeffrey Eisele C/O Apellis Pharmaceuticals, Inc.
100 Fifth Avenue, 3Rd Floor
Waltham MA 02451
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-29 279 $64.14 58,179 No 4 S Direct
Common Stock Disposition 2024-01-30 971 $65.53 57,208 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/26/2024.
  2. This is a scheduled sale from an established 10b5-1 plan.